17.43MMarket Cap
LossP/E TTM
Atossa Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-30The current valuation score of Atossa Therapeutics Inc is 7.10, ranking 261 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.03, which is -9.46% below the recent high of -0.03 and -75053.63% above the recent low of -23.82.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.